Nonclinical in vivo animal studies have to be completed before starting clinical studies of the pharmacokinetic behavior of a drug in humans. The drug exposure in animal studies is often measured by the area under the concentration versus time curve (AUC). The classic complete data design, where each animal is sampled for analysis once per time point, is usually only applicable for large animals. In the case of rats and mice, where blood sampling is restricted, the batch design or the serial sampling design needs to be considered. In batch designs samples are taken more than once from each animal, but not at all time points. In serial sampling designs only one sample is taken from each animal. In this paper we present an estimator for the A...
In clinical pharmacokinetic (PK) studies multiple blood samples are taken for each enrolled patient,...
Objectives: In many pharmaceutical studies multiple blood samples are taken for each enrolled patien...
An estimation of the average value of pharmacokinetic parameters in a group of animals provides limi...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...
Pharmacokinetic studies are commonly performed using the two-stage approach. The first stage involve...
Based on toxicokinetic studies of a destructive sampling design, this work was aimed at selecting th...
International audienceThe problem of interest is to estimate the concentration curve and the area un...
In pharmacokinetic (PK) studies, blood samples are taken over time on subjects after the administrat...
The area under the ROC curve (AUC) and partial area under the ROC curve (pAUC) are summary measures ...
<p>In traditional toxicology trials, pharmacokinetics (PK) is investigated in the satellite group of...
Crossover studies are frequently used in clinical research as they allow within-subject comparisons ...
Pharmacokinetic studies aim to study how a compound is absorbed, distributed, metabolised, and excre...
Le problème d'intérêt est d'estimer la fonction de concentration et l'aire sous la courbe (AUC) à tr...
In clinical pharmacokinetic (PK) studies multiple blood samples are taken for each enrolled patient,...
Objectives: In many pharmaceutical studies multiple blood samples are taken for each enrolled patien...
An estimation of the average value of pharmacokinetic parameters in a group of animals provides limi...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...
Nonclinical in vivo animal studies have to be completed before starting clinical studies of the phar...
Pharmacokinetic studies are commonly performed using the two-stage approach. The first stage involve...
Based on toxicokinetic studies of a destructive sampling design, this work was aimed at selecting th...
International audienceThe problem of interest is to estimate the concentration curve and the area un...
In pharmacokinetic (PK) studies, blood samples are taken over time on subjects after the administrat...
The area under the ROC curve (AUC) and partial area under the ROC curve (pAUC) are summary measures ...
<p>In traditional toxicology trials, pharmacokinetics (PK) is investigated in the satellite group of...
Crossover studies are frequently used in clinical research as they allow within-subject comparisons ...
Pharmacokinetic studies aim to study how a compound is absorbed, distributed, metabolised, and excre...
Le problème d'intérêt est d'estimer la fonction de concentration et l'aire sous la courbe (AUC) à tr...
In clinical pharmacokinetic (PK) studies multiple blood samples are taken for each enrolled patient,...
Objectives: In many pharmaceutical studies multiple blood samples are taken for each enrolled patien...
An estimation of the average value of pharmacokinetic parameters in a group of animals provides limi...